Showing posts with label zibanejad. Show all posts
Showing posts with label zibanejad. Show all posts

Wednesday, February 5, 2025

Emergency Cap Court session: Does the rising cap change the verdict on these stars?

But the cap is going up.

For years, it’s been the go-to excuse for any questionable contract signed in the NHL. Aside from the years immediately following the pandemic, the NHL’s cap ceiling always goes up, at least a little bit. And that meant that any criticism of a contract would immediately be met by a condescending reminder that the cap would eventually go up. A rising cap was an optimistic fan’s – and an overspending GM’s – very best friend, even when it was obviously nonsense.

Except…

Well, now the cap is really going up. Like, way up, by an amount that’s enough to have us reconsidering what we thought we knew about how the league’s economics work. So today, I’m convening a special session of Cap Court, the feature where we put contracts on trial. We’re going to reach back into the last few editions of this column to find deals that got the dreaded “bad contract” verdict, and give them another look based on last week’s news.

I went back through the archives and found five contracts that have a solid case for appeal. Let’s see if any of those can reverse the original call.

>> Read the full post at The Athletic

(Want to read this post on The Athletic for free? Sign up for a free trial.)




Wednesday, October 16, 2024

Do Mark Scheifele or Mika Zibanejad have bad contracts? NHL Cap Court returns

Welcome back to Cap Court, where we put the questionable deals of NHL stars on trial to find out whether they deserve the dreaded "bad contract" label.

As always, we’re viewing “bad” contracts through the lens of the team that’s stuck with them, since that’s ultimately how fans are forced to do it, even though we’d never begrudge a player taking on offer that’s put in front of them. Importantly, we’re also only looking at contracts from this day forward – a deal could have made sense and even provided value for the first few years, but we’re only looking at what’s left on the books.

We’ve been doing this long enough that names like Jonathan Toews, Carey Pruce and Jakub Voracek have been on the docket. Heck, one of the early editions featured Ryan Suter and Oliver Ekman-Larsson, a combined five teams and three buyouts ago. Have all of our calls been proven right? Look, we’ll do the cross-examining around here, thank you very much.

This time around, we’ve got five more names. We'll start with a big-market blueliner...

>> Read the full post at The Athletic